Araştırma Makalesi

High Serum Osmolality May Predict the Disease Severity in Patients with Acute Ulcerative Colitis

Cilt: 5 Sayı: 2 30 Haziran 2020
PDF İndir
EN TR

High Serum Osmolality May Predict the Disease Severity in Patients with Acute Ulcerative Colitis

Abstract

Objective: Ulcerative colitis (UC) is characterised by chronic immun- mediated inflammation of the colonic mucosa. The Truelove and Witts (TW) criteria have been used to define the severity of the UC. Otherhand, a simplier and unified laboratory tool is needed for better definition of high risk patients with UC. The aim of the study, especially in emergency service applications, was to determine the usefulness of serum osmalality as a biomarker which can easily and rapidly predict the severity of the disease, in which the patient will be advised to be hospitalized after the symptomatic treatment. 
Materials and Methods: In this single-center, retrospective cohort study, we collected data of 62 hospitalized patients with UC such as demographic characteristics and blood sample results evaluated by clinicians. Truelove and Witts (TW) scores of the patients along with serum osmolality were calculated. Stata 14.0. package program was used for data analysis. P <0.05 was considered statistically significant. 
Results: According to our results, patients with hyperosmolality were more likely to have severe UC as defined by having higher scores of TW criteria at baseline.
Conclusion: As a conclusion, serum osmolality can be considered as an useful predictor to demonstrate the severity of the disease.

Keywords

Kaynakça

  1. 1. Dulai PS, Jairath V. Acute severe ulcerative colitis: latest evidence and therapeutic implications. Ther Adv Chronic Dis. 2018;9(2):65-72.
  2. 2. Danese S, Banerjee R, Cummings JF et al. Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy-Access to Rapid Treatment (iSTART) approach. Intest Res. 2018;16(4):522-528.
  3. 3. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. Br Med J. 1954;2:375-378.
  4. 4. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571-607.
  5. 5. Brown SR, Haboubi N, Hampton J, George B, Travis SP. ACPGBI. The management of acute severe colitis: ACPGBI position statement. Colorectal Dis. 2008;10(Suppl 3):8-29.
  6. 6. Jain S, Kedia S, Bopanna S. et al. Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study. Intest Res. 2018;16(1):69-74.
  7. 7. Vaduganathan M, Marti CN, Mentz RJ, Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure. Am J Cardiol. 2016;117(7):1144-1150.
  8. 8. Liamis G, Filippatos TD, Liontos A, Elisaf M1. Serum osmolal gap in clinical practice: usefulness and limitations. Postgrad Med. 2017;129(4):456-459.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

30 Haziran 2020

Gönderilme Tarihi

9 Ocak 2019

Kabul Tarihi

18 Mart 2019

Yayımlandığı Sayı

Yıl 2020 Cilt: 5 Sayı: 2

Kaynak Göster

AMA
1.Vural A, Vural A, Vural S, Turfan S, Dülger AC. High Serum Osmolality May Predict the Disease Severity in Patients with Acute Ulcerative Colitis. OTSBD. 2020;5(2):324-329. doi:10.26453/otjhs.510969

Creative Commons Lisansı
 

Online Türk Sağlık Bilimleri Dergisi Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır.

Bu, Creative Commons Atıf Lisansı (CC BY-NC 4.0) şartları altında dağıtılan açık erişimli bir dergidir. Orijinal yazar(lar) veya lisans verenin adı ve bu dergideki orijinal yayının kabul görmüş akademik uygulamaya uygun olarak atıfta bulunulması koşuluyla, diğer forumlarda kullanılması, dağıtılması veya çoğaltılmasına izin verilir. Bu şartlara uymayan hiçbir kullanım, dağıtım veya çoğaltmaya izin verilmez.

Makale gönderme süreçleri ve "Telif Hakkı Devir Formu" hakkında yardım almak için tıklayınız.